Collplant Biotechnologies Ltd Asset Turnover Ratio (CLGN), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Collplant Biotechnologies Ltd  (NASDAQ: CLGN)
 

Collplant Biotechnologies Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Collplant Biotechnologies Ltd asset turnover ratio, the ability of Collplant Biotechnologies Ltd's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.13 in the fourth quarter (Dec 31 2025), yet the ratio remained below the average, as CLGN's position remain challenging.

Within sector 149 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from to 3049.

Asset Turnover Ratio Definition



CLGN Asset Turnover Ratio (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2024)
II. Quarter
Y / Y Asset Change 0.77 % -63.25 % -67.81 % -72.89 % 16.51 %
Y / Y Revenue Change 852.21 % - - - -
Asset Turnover Ratio (TTM) 0.13 - 0.49 - 0.56
CLGN's Total Ranking # 3049 # # # #
Seq. Asset Change 421.14 % -51.63 % 106.72 % -80.66 % 90.07 %
Seq. Revenue Change - - - - -97.73 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 150
Healthcare Sector # 444
Overall Market # 3049

Asset Turnover Ratio Statistics
High Average Low
0.57 0.28 0.01
(Dec 31 2020)   (Dec 31 2022)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Moderna Inc   0.16 $ 1,944.000  Millions$ 12,296.750  Millions
Inspiremd Inc   0.16 $ 8.649  Millions$ 54.972  Millions
Maxcyte inc   0.15 $ 33.026  Millions$ 216.424  Millions
Scilex Holding Company  0.15 $ 30.253  Millions$ 200.898  Millions
Newgenivf Group Limited  0.14 $ 4.726  Millions$ 32.723  Millions
Skinvisible Inc   0.14 $ 0.020  Millions$ 0.139  Millions
Lineage Cell Therapeutics Inc   0.14 $ 14.556  Millions$ 101.194  Millions
Innate Pharma Sa  0.14 $ 10.086  Millions$ 70.245  Millions
Femasys Inc   0.14 $ 2.293  Millions$ 16.018  Millions
Xencor Inc  0.14 $ 125.576  Millions$ 882.105  Millions
Ginkgo Bioworks Holdings Inc   0.14 $ 170.155  Millions$ 1,208.333  Millions
Foghorn Therapeutics Inc   0.14 $ 30.909  Millions$ 221.998  Millions
Nurix Therapeutics Inc   0.14 $ 83.980  Millions$ 604.301  Millions
Biocorrx Inc   0.14 $ 0.797  Millions$ 5.791  Millions
Proqr Therapeutics N v   0.14 $ 17.815  Millions$ 131.196  Millions
Voyager Therapeutics Inc   0.13 $ 40.374  Millions$ 303.983  Millions
Cannapharmarx Inc   0.13 $ 1.362  Millions$ 10.336  Millions
Biontech Se  0.13 $ 3,214.288  Millions$ 24,627.232  Millions
Royalty Pharma Plc  0.13 $ 2,378.193  Millions$ 18,724.829  Millions
Cervomed Inc   0.12 $ 4.007  Millions$ 32.537  Millions
Scisparc Ltd  0.12 $ 0.856  Millions$ 7.001  Millions
Kamada Ltd   0.12 $ 44.678  Millions$ 374.799  Millions
C4 Therapeutics Inc   0.12 $ 35.947  Millions$ 310.154  Millions
Lucid Diagnostics Inc   0.11 $ 4.706  Millions$ 41.277  Millions
Scinai Immunotherapeutics Ltd  0.11 $ 1.311  Millions$ 11.679  Millions
Autolus Therapeutics Plc  0.11 $ 75.388  Millions$ 679.584  Millions
Vystar Corporation  0.11 $ 0.055  Millions$ 0.498  Millions
Lipocine Inc   0.11 $ 1.977  Millions$ 18.039  Millions
Bolt Biotherapeutics Inc   0.11 $ 7.695  Millions$ 70.791  Millions
Seastar Medical Holding Corp  0.11 $ 1.234  Millions$ 11.417  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.